Dr. Rikin Kartikbhai Shah

About Dr. Rikin Kartikbhai Shah

Dr. Rikin Kartikbhai Shah, M.D., is a board-certified pediatric hematologist-oncologist specializing in the care of children, adolescents, and young adults with cancer and blood disorders. He practices at the Haley Center for Children’s Cancer and Blood Disorders at Orlando Health Arnold Palmer Hospital for Children and is affiliated with Orlando Health Orlando Regional Medical Center. Dr. Shah has over 15 years of clinical experience and is recognized for his expertise in advanced therapies, including stem cell transplantation and cellular therapies such as CAR-T treatment. Dr. Shah earned his medical degree from Smt. N.H.L. Municipal Medical College in Ahmedabad, India. He completed his pediatric residency at Texas Tech University Health Sciences Center and went on to pursue fellowship training in Pediatric Hematology-Oncology at the University of Oklahoma Health Science Center. He further specialized with an additional fellowship in Pediatric Stem Cell Transplantation and Cellular Therapy at Baylor College of Medicine. In addition to his clinical work, Dr. Shah is actively involved in research and academic medicine, with multiple peer-reviewed publications and participation in clinical studies. He is a member of leading professional organizations, including the American Society of Hematology and the Children’s Oncology Group, reflecting his commitment to advancing pediatric cancer care.

Professional Experience

Arnold Palmer Hospital for Children, Orlando Health

Director of Pediatric Bone Marrow Transplantation and Cellular Therapy, Haley Center for Children’s Cancer and Blood Disorders · Orlando, FL, United States

University of Oklahoma Health Science Center

Assistant Professor, Department of Pediatrics, Pediatric Hematology/Oncology · Oklahoma City, OK, United States

University of Oklahoma Health Sciences Center

Associate Director of Pediatric Hematology/Oncology Fellowship Program, Jimmy Everest Section · Oklahoma City, OK, United States

Education & Training

Smt. N.H.L Municipal Medical College

Bachelor of Medicine, Bachelor of Surgery · Ahmedabad, India

Texas Tech University Health Science Center at Amarillo

Pediatric Resident, Department of Pediatrics · Amarillo, TX, United States

Baylor College of Medicine

Pediatric Stem Cell Transplantation Fellow, Department of Pediatric Hematology/Oncology · Houston, TX, United States

Research & Publications

Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance

Authors: Stenger E, Xiang Y, Wetzel M, Gillespie S, Chellapandian D, Shah R, Arnold SD, Bhatia M, Chaudhury S, Eckrich MJ, Kanter J, Kasow KA, Krajewski J, Nickel RS, Ngwube AI, Olson TS, Rangarajan HG, Wobma H, Guilcher GMT, Horan JT, Krishnamurti L, Shenoy S, Abraham A.

Transplant Cell Ther.

Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease

Authors: Srinivasan A, Bajana S, Pankow A, Yuen CH, Shah RK, Sun XH.

BMC Immunology

IDH1 mutated acute myeloid leukemia in a child with metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria

Authors: Srinivasan A, Zhou Y, Scordino TA, Prabhu SG, Wierenga AM, Simon G, Wierenga KJ, Thompson JC, Shah RK, Sinha A.

Pediatric Hematology and Oncology

Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis

Authors: Borga C, Park G, Foster C, Burroughs-Garcia J, Marchesin M, Shah RK, Hasan A, Ahmed ST, Bresolin S, Batchelor L, Scordino TA, Miles RR, Te Kronnie G, Regens JL, Frazer JK.

Leukemia

Encephalocraniocutaneous Lipomatosis

Authors: Bavle AA, Shah RK, Gross N, Gavula T, Ruiz-Elizalde AR, Wierenga KJ, McNall-Knapp R.

Journal of Pediatric Hematology/Oncology

A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis

Authors: Shah RK, Munson M, Wierenga KJ, Pokala HR, Newburger PE, Crawford DF.

Pediatric Blood & Cancer

Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma

Authors: Miles RR, Shah RK, Frazer JK.

British Journal of Haematology

N-acetylcysteine renoprotection in methotrexate induced nephrotoxicity and its effects on B-cell lymphoma

Authors: Singh R, Shah RK, Turner C, Regueira O, Vasylyeva TL.

Indian Journal of Medical and Paediatric Oncology

N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide

Authors: Hanly L, Rieder MJ, Huang SH, Vasylyeva TL, Shah RK, Regueira O, Koren G.

Journal of Population Therapeutics and Clinical Pharmacology

Multiple liver abscesses in a child

Authors: Shah RK, Sethi VK, Bridges WJ, Abiodun JO.

Open Journal of Pediatrics

Onychomadesis secondary to penicillin allergy in a child

Authors: Shah RK, Uddin M, Fatunde OJ.

The Journal of Pediatrics

Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies

Authors: Shah RK, Veerapandiyan A, Winchester S, Gallentine W, Mikati MA.

Pediatric Neurology

Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study

Authors: Horan F, Bendiak G, Abraham A, Liu K, Gillespie S, Chellapandian D, Shah RK, Bhatia M, Chaudhury S, Eckrich M, Jaroscak J, Kasow K, Krajewski J, Nguwube A, Horan J, Krishnamurti L, Shenoy S, Guilcher G, Stenger E.

Transplantation and Cellular Therapy

Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study

Authors: Stenger E, John TD, Chellapandian D, Shah RK, Gillespie S, Xiang Y, Liu K, Bhatia M, Guilcher GMT, Jaroscak J, Kasow KA, Krajewski J, Ngwube AI, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A.

Blood

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

Authors: John TD, Chellapandian D, Shah RK, Gillespie S, Liu K, Xiang Y, Bhatia M, Chaudhury S, Eckrich MJ, Guilcher GMT, Jaroscak J, Kasow KA, Krajewski J, Ngwube AI, Olson TS, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A, Stenger E.

Blood

Recovery of innate lymphoid cells after allogeneic stem cell transplant: A single institution pilot study

Authors: Srinivasan A, Shah RK.

The Journal of Immunology

Retrospective Review of Use of Individualized Dosing of Rabbit Anti-Thymocyte Globulin on Outcomes in Pediatric Post Allogeneic Stem Cell Transplant Patients

Authors: Srinivasan A, Shah RK, Anderson M, Stubblefield A, Admiraal R, Boelens J-J, Crawford DF.

BBMT

Decreasing the Rate of Asparaginase Reactions due to Hyperammonemia

Authors: McNall-Knapp R, Sims K, Shah RK, Mazzone S, Peek L, Howard S.

Pediatric Blood and Cancer